Hartung S, Kolip P, Kruckenberg B, Lehmann F, Löchel N, Merta J, Noweski M, Nöcker G, Plaumann M, Pospiech S, Reemann H, Rüden U von, Schaefer I, Schauermann L, Töppich J, Volkenand K, Walter U, Weber J

by the p38MAPK-MK2 axis and affects NF-κB-mediated transcription. Shrestha A, Bruckmueller H, Kildalsen H, Kaur G, Gaestel M, Wetting HL, Mikkola I, Seternes OM. Sci Rep. 2020 Jul 9;10(1):11388. 2019 The [...] and infection Menon MB*, Gropengießer J*, Fischer J, Novikova L, Deuretzbacher A, Lafera J, Schimmeck H, Czymmeck N, Ronkina N, Kotlyarov A, Aepfelbacher M, Gaestel M* & Ruckdeschel K* (2017)(* equal con

blood sampling >> sample preparation for sequencing (~ 5:30 h) >> rapid trio genome sequencing (~ 30:00 h) >> bioinformatical analysis (~ 06:00 h) >> diagnostic evaluation >> results discussed in 2nd int [...] questions on indication-related outcomes, and a positive overall score indicates clinical actionability, e.g. a change in medication. The mean C-GUIDE score for diagnostic outcomes in the Baby Lion study was 18

L, Müller M, Izykowski N, Hong J, Hong K, Kim SH, Dorsch M , Mahadeva R, Laenger F, Kreipe H, Braun A, Shahaf G, Lewis EC, Welte T, Dinarello CA, Janciauskiene S. Anti-inflammatory and immunomodulatory

with a strong focus on noncoding RNAs, such as microRNAs, long-noncoding RNAs and circular RNAs (e.g. Nature, 2008; Nature Comm 2012; Science Transl Med 2016; Circ Res 2017). The Institute is also interested [...] companies and larger pharmaceutical industries. A recent spin-off of IMTTS is Cardior Pharmaceuticals GmbH ( www.cardior.de ), that had licensed IMTTS technology to develop innovative ncRNA-based treatment

1186/s13104-023-06288-0 Krüger K , Rossol S, Krauth C, Buggisch P, Mauss S, Stoehr A, Klinker H, Böker K, Teuber G, Stahmeyer J (2022). Real-world experience for the outcomes and costs of treating hepatitis [...] Antivirals. (Posterpräsentation - DGGÖ Jahrestagung - Hamburg 2018) Krüger K , Blase L, Schmiemann G, Lingner H. ManRück: Manuelle Therapie & Funktionskapazität bei akuten unspezifischen Rückenschmerzen. ( [...] https://doi.org/10.1371/journal.pone.0288905 Krüger K , Schmetsdorf J, Pavlovic M, Runde W, Zechel G, Hemken N, Krauth C (2023). Evaluation of a multimodal pain therapy approach with relapse prophylaxis

komplettes Spektrum beinhaltet: H erzchirurgie / Kunstherzimplantation T horaxchirurgie / VATS (Videoassistierte Thoraxchirurgie) T ransplantationen von Herz und Lungen G efäßchirurgie / Stentimplantation

s. Präv Gesundheitsf doi.org/10.1007/s11553-024-01133-z Oppermann L , Bornemann A, Martinović G, Seidel G, Dierks M-L (2023). Reichweite von Gesundheitsinformationen über YouTube am Beispiel der digitalen [...] Zheng M, Popp J, Eckert K, Geidl W, Blaschke S, Schmid J, Grüne E, Oppermann L , Liphardt A-M, Morf H, Weissenfels A, Pfeifer K (2024). Competencies for health-enhancing physical activity are associated [...] Science GMS Publishing House; 2024. DocAbstr. 25. doi: 10.3205/24gmds291 Oppermann L , Posselt J, Seidel G, Dierks M-L (2024). Förderung bewegungsbezogener Gesundheitskompetenz am Arbeitsplatz – qualitative

s F FACT Fortbildungen Forum-Lehre Freisemester Freiquintil G Gefährdungsbeurteilung für schwangere Studentinnen Gleichstellung Gute Lehre H Habilitation Handreichungen HannibaL Hinweise zu Rechtsfragen

2025;, otaf040, doi.org/10.1093/crocol/otaf040 Pueschel, L.; Nothacker, S.;Kuhn, L.;Wedemeyer, H.; Lenzen, H.; Wiestler, M . Assessing HighlyProcessed Food Consumption in Patients with Inflammatory Bowel [...] Clin. Med. 2025, 14, 3819. doi.org/10.3390/jcm14113819 Pueschel L; Nothacker, S.; Wedemeyer, H.; Lenzen, H.; Wiestler, M . Validation of the German Version of the Screening Questionnaire for Highly Processed [...] Aktuel Ernahrungsmed 2025 (efirst). doi:10.1055/a-2580-0972 Pueschel L, Hupa-Breier K, Wedemeyer H, Lenzen, H, Wiestler, M. Food-related Quality of Life in patients with Inflammatory Bowel Disease: Translation